Photocure news
WebMar 21, 2024 · Oslo, Norway, March 21, 2024 – Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces Karl Storz’s continued commitment to blue light cystoscopy with plans to maximize the ongoing rollout of its new high-definition rigid blue light cystoscopy (BLC ®) system, Saphira™.Due to previously disclosed component supply … WebFeb 7, 2024 · "The successful FDA approval is great news for the bladder cancer community in the U.S.," commented Geoffrey Coy, Vice President and General Manager, North America at Photocure.
Photocure news
Did you know?
WebAug 25, 2024 · The parties entered into a final agreement today, stipulating that commercial rights will transfer to Photocure on January 1st, 2024. The reacquisition of marketing and distribution rights enables ... WebAug 10, 2024 · Oslo, Norway, 10 August 2024: Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q2 2024: NOK 88.9 million), and a positive EBITDA of NOK 1.4 million (NOK 5.8 million). Karl Storz’s new high-definition blue light system is expected to become commercially available in the ...
WebAug 10, 2024 · OSLO, Norway, Aug. 10, 2024 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a ... WebApr 12, 2024 · PR Newswire. OSLO, Norway, April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. …
WebMar 30, 2024 · Photocure Technology; Our products; Research support; News; Our Impact. Patient Registries And Real-World Evidence; Bladder cancer community support; … WebFeb 23, 2024 · OSLO, Norway , Feb. 23, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 94.9 million in the fourth quarter of 2024 (Q4 2024: NOK 94.2 million ), and an EBITDA of minus NOK 16.9 million ( NOK -5.5 million ). The total revenues increased 10% to NOK 104.2 million and there were 57 blue …
WebApr 12, 2024 · The Board of Directors of Photocure ASA has approved the annual accounts for 2024. The financial statements and annual report for the financial year 2024 are together with the ESG report and auditor's report attached to this notice. The ESEF file for 2024 is also attached. The documents are enclosed and also made available at the company's ...
WebApr 12, 2024 · PR Newswire. OSLO, Norway , April 12, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 3 May 2024 at 17:00 hours (CEST), virtual through the general meeting portal administered by Euronext Securities Oslo (the "Euronext Securities Portal"). The general meeting will be webcasted ... fnq rugby unionWebPhotocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. … fnq fuse blockWebHuman Resources at Photocure ASA. The position of Account Manage r is responsible for growing Cysview® sales in New England territory. Responsibilities include account … fnq water athertonWebMar 14, 2024 · OSLO, Norway, March 14, 2024 /PRNewswire/ -- Photocure ASA(OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the European Association of Urology congress (EAU) in Milan, Italy, highlighting the benefits of Blue Light Cystoscopy (BLC ®) in Bladder Cancer … fnq shootingWebMar 14, 2024 · Photocure is commercializing Cysview/Hexvix directly in the U.S. and Europe and has strategic partnerships for the commercialization of Hexvix/Cysview in China, Chile, Australia, New Zealand and ... fnq schoolsWebApr 11, 2024 · Price History & Performance. Summary of all time highs, changes and price drops for Photocure. Historical stock prices. Current Share Price. kr57.90. 52 Week High. kr119.90. 52 Week Low. kr54.80. fnq wastegreenway mecklenburg county